Individuals with reduced GPX1 activity exhibit an increased incidence of oxidative stress-related diseases such as breast, colon, prostate, bladder and lung cancers, coronary artery disease, and also, low bone mineral density [36] and osteoarthropathy [37]. This evidence concerns the gene GPX1 and glycogen storage disease VI.